The ethics of placebo-controlled trials: Methodological justifications

Contemporary Clinical Trials

Volumn 36, Issue 2, 2013, Pages 510-514

  Millum, Joseph ^a   Grady, Christine ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Ethics; Placebo control; Randomized controlled trial

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ARTESUNATE; PLACEBO; ZIDOVUDINE;

ALLERGIC RHINITIS; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); HEALTH CARE QUALITY; HEALTH HAZARD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; MEDICAL RESEARCH; METHODOLOGY; PLACEBO EFFECT; POSTTRAUMATIC STRESS DISORDER; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESEARCH ETHICS; TREATMENT WITHDRAWAL;

ETHICS; PLACEBO CONTROL; RANDOMIZED CONTROLLED TRIAL;

ETHICS, RESEARCH; HELSINKI DECLARATION; HUMANS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84885910043     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2013.09.003     Document Type: Article

References (32)

1. Presidential Commission for the Study of Bioethical Issues. Moral Science: Protecting Participants in Human Subjects Research. Washington DC 2011.
2. Council for International Organizations of Medical Sciences, World Health Organization, International ethical guidelines for biomedical research involving human subjects 2002, World Medical Association, [Guideline 11].
3. Emanuel E.J., Miller F.G. The ethics of placebo-controlled trials-a middle ground. N Engl J Med 2001, 345(12):915-919.
4. Temple R., Ellenberg S.S. Placebo-controlled trials and active-control trials in the evaluation of new treatments. I. Ethical and scientific issues. Ann Intern Med 2000, 133:455-463.
5. World Medical Association, Declaration of Helsinki at, [Paragraph 32]. http://www.wma.net/en/30publications/10policies/b3/.
6. Lie R.K., Emanuel E., Grady C., Wendler D. The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. J Med Ethics 2004, 30:190-193.
7. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331(18):1173-1180.
8. Lurie P., Wolfe S.M. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997, 337:853-855.
9. Angell M. The ethics of clinical research in the Third World. N Engl J Med 1997, 337:847-849.
10. Varmus H., Satcher D. Ethical complexities of conducting research in developing countries. N Engl J Med 1997, 337:1003-1005.
11. Wendler D., Emanuel E.J., Lie R.K. The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs?. Am J Public Health 2004, 94:923-928.
12. Grady C. Science in the service of healing. Hastings Cent Rep 1998, 28(6):34-38.
13. Khanna S., Vieta E., Lyons B., Grossman F., Eerdekens M., Kramer M. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 2005, 187:229-234.
14. Basil B., Adetunji B., Mathews M., Budur K. Trial of risperidone in India-concerns. Br J Psychiatry 2006, 188:489-490.
15. Khanna S., Vieta E., Lyons B., Grossman F., Kramer M., Eerdekens M. Trial of risperidone in India-concerns. Authors' reply. Br J Psychiatry 2006, 188:491.
16. Pigeot I., Schäfer J., Röhmel J., Hauschke D. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. Stat Med 2003, 22(6):883-899.
17. Nusbaum N.J. Making "me-too" drugs benefit the public. Am J Med Qual 2002, 17(6):215-217.
18. Nelson C.A., Zeanah C.H., Fox N.A., Marshall P.J., Smyke A.T., Guthrie D. Cognitive recovery in socially deprived young children: the Bucharest Early Intervention Project. Science 2007, 318:1937-1940.
19. Rid A. When is research socially valuable? Lessons from the Bucharest Early Intervention Project: commentary on a case study in the ethics of mental health research. J Nerv Ment Dis 2012, 200(3):248-249.
20. Emanuel E.J., Wendler D., Killen J., Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis 2004, 189(5):930-937.
21. Lurie P., Wolfe S.M. Commentary 9.2. The developing world as the "answer" to the dreams of pharmaceutical companies: the surfaxin story. Ethical issues in International Biomedical Research: a casebook 2007, 159-170. Oxford University Press. J.V. Lavery, C. Grady, E.R. Wahl, E.J. Emanuel (Eds.).
22. Editors for the IOM Committee on cancer clnical trials and the NCI Cooperative Group Program. A national cancer clinical trials system for the 21st century, Washington DC 2010, S.J. Nass, H.L. Moses, J. Mendelsohn (Eds.).
23. Doody R.S., Raman R., Farlow M., Iwatsubo T., Vellas B., Joffe S., et al. Alzheimer's disease cooperative study steering committee, Siemers E, Sethuraman G, Mohs R; Semagacestat study group. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med 2013, 369(4):341-350.
24. Burger R.A., Brady M.F., Bookman M.A., Fleming G.F., Monk B.J., Huang H., et al. Gynecologic Oncology Group. Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 2011, 365(26):2473-2483.
25. Raskind M.A., Peterson K., Williams T., Hoff D.J., Hart K., Holmes H., et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry 2013, 170:1003-1010.
26. Olsen E.A., Whiting D.A., Savin R., Rodgers A., Johnson-Levonas A.O., Round E., et al. Male pattern hair loss Study Group Global photographic assessment of men aged 18 to 60years with male pattern hair loss receiving finasteride 1mg or placebo. J Am Acad Dermatol 2012, 67(3):379-386.
27. Patel P., Holdich T., von Weikersthal-Drachenberg KJ Fischer, Huber B. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. J Allergy Clin Immunol 2013, [in press] [Epub ahead of print]. 10.1016/j.jaci.2013.05.032.
28. Albrecht E., Morfey D., Chan V., Gandhi R., Koshkin A., Chin K.J., et al. Single-injection or continuous femoral nerve block for total knee arthroplasty?. Clin Orthop Relat Res 2013, [in press] [Epub ahead of print]. 10.1007/s11999-013-3192-3.
29. Mease P.J., Fleischmann R., Deodhar A.A., Wollenhaupt J., Khraishi M., Kielar D., et al. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis 2013, [in press] [Epub ahead of print]. 10.1136/annrheumdis-2013-203696.
30. Temple R., Ellenberg S.S. Placebo-controlled trials and active-control trials in the evaluation of new treatments. I. Ethical and scientific issues. Ann Intern Med 2000, 133:455-463.
31. Wiktor S.Z., Ekpini E., Karon J.M., Nkengasong J., Maurice C., Severin S.T., et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, CÔte d'Ivoire: a randomised trial. Lancet 1999, 353(9155):781-785.
32. Kitua A., Folb P., Warsame M., Binka F., Faiz A., Ribeiro I., et al. The use of placebo in a trial of rectal artesunate as initial treatment for severe malaria patients en route to referral clinics: ethical issues. J Med Ethics 2010, 36:116-120.